Free Newsletter
Pall, Sartorius deals advance disposable bioreactors
Single-use technology users continue to enjoy supplier pairings that enhance bioprocess efficiency while bringing disposables a capability step closer to stainless steel systems. Pall and New Brunswick have teamed to combine the former's single-use biocontainer with the latter's controller system. Separately, Sartorius Stedim Biotech has re-upped with ATMI for continued marketing and distribution of ATMI's Magnetic Mixer and LevMixer systems.
By adding the CelliGen bioprocess controller system, Pall is extending the range of its Allegro disposable bioreactor's upstream application capabilities to span process development through full-scale cGMP production.
For Sartorius Stedim, the addition of the mobile Magnetic Mixer system brings aggressive mixing capabilities--for buffer and media preparation, as well as final product formulation--to various bioprocessing volumes. Sartorius also retains its rights for the single-use LevMixer system, which levitates and drives a single-use impeller inside sterile bags. Its uses include liquid-to-liquid applications in downstream purification and sensitive formulation steps.
- read this article on the Pall/New Brunswick collaboration
- here's the Sartorius Stedim announcement
Related Articles:
Sartorius, Pall reap vaccine-gear bounty
Vendors jockey for bioprocess position
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: